ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS

CHICAGO, March 4, 2026 /PRNewswire/ -- Ziegler, a specialty investment bank, is pleased to announce that it served as the exclusive financial advisor to Preferred Vascular Group (PVG) in connection with its acquisition by Surgery Partners (NASDAQ: SGRY), a leading operator of surgical facilities and ancillary services. Founded in 2005, PVG is a leading Ambulatory Surgical Center (ASC) operator focused specifically on dialysis access procedures, with eight ASCs in Georgia and Ohio.

PRNewsWire • Mar 4, 2026

Surgery Partners, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Surgery Partners, Inc. (NASDAQ: SGRY). The investigation focuses on Surgery Partners' executive officers and whether investor losses may be recovered under federal securities laws.

GlobeNewsWire • Mar 4, 2026

Surgery Partners' Plunge Offers An Opportunity For Upside (Rating Upgrade)

Surgery Partners saw shares drop 14.1% after Q4 2025 results, with revenue beating estimates but profitability disappointing. SGRY expanded surgical facilities and increased revenue per case, but total case volume fell due to asset sales, impacting short-term results. Despite mixed profitability, SGRY trades at attractive EV/EBITDA and operating cash flow multiples versus peers, supporting a soft ‘buy' upgrade.

Seeking Alpha • Mar 4, 2026

Surgery Partners, Inc. (SGRY) Q4 2025 Earnings Call Transcript

Surgery Partners, Inc. (SGRY) Q4 2025 Earnings Call Transcript

Seeking Alpha • Mar 3, 2026

Surgery Partners (SGRY) Lags Q4 Earnings Estimates

Surgery Partners (SGRY) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.44 per share a year ago.

Zacks Investment Research • Mar 2, 2026

Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details

BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2025 results after market close on Monday, March 2, 2026, to be followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. (Eastern Time).

GlobeNewsWire • Feb 24, 2026

Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million

Irenic Capital sold 1,047,583 shares of Surgery Partners in the fourth quarter; the estimated transaction value was $19.25 million based on average fourth-quarter pricing. The quarter-end position value decreased by $23.19 million, reflecting both share sales and price changes.

The Motley Fool • Feb 23, 2026

Surgery Partners (SGRY) Moves 7.7% Higher: Will This Strength Last?

Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Investment Research • Feb 12, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY

NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Surgery Partners, Inc. ("Surgery Partners" or the "Company") (NASDAQ: SGRY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

PRNewsWire • Dec 11, 2025

Surgery Partners, Inc. Announces Add-On Senior Notes Offering

BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the “Issuer”), intends to offer, subject to market and other considerations, an additional $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”). The Notes will be guaranteed (the “Guarantees”) on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees its obligations under its senior secured credit facilities. The notes will be issued as part of the same series as the Issuer's 7.250% senior notes due 2032 originally issued in April 2024.

GlobeNewsWire • Dec 11, 2025